Viral Warts Treatment Market Share

 North America industry is predicted to hold largest revenue share by 2037, owing to rising awareness regarding different treatment options, well-established healthcare infrastructure and high healthcare spending in the region. The market in the North America industry is likely to hold largest revenue share by 2036, owing to rising awareness regarding different treatment options, well-established healthcare infrastructure and high healthcare spending in the region. As per the data provided by the Centers for Disease Control and Prevention, the total national health expenditure in the United States accounted for a value of USD 3.6 trillion in 2018, or USD 11,172 per capita. The total value of the same as share of GDP was 17.7 percent that year. In addition, increase in drug approvals is also expected to boost the region’s viral warts treatment market growth in the coming years. Moreover, the market in Europe is also predicted to acquire a notable share during the forecast period, which can be credited to the growing research and development activities in the healthcare sector, and presence of prominent viral warts treatment market players in the region.